Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
Ankoor H. Patel; Gaurav N. Pathak; Alexander Chen; Patricia Greenberg; Natale Mazzaferro; Anish Patel; Naveen Mallangada; Carlos D. Minacapelli; Kaitlyn Catalano; Hansel Suthar; Vinod K. Rustgi;
10.1016/j.aohep.2024.101510
Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021
Stephen E. Congly; Mayur Brahmania; Carla S. Coffin;
10.1016/j.aohep.2024.101509
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance
Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;
Ann Hepatol. 2023;28: